5 of Last Week's Biggest Winners

What's better than momentum? Mo' momentum. Let's take a closer look at five of this past week's biggest scorchers.

Company

April 12

Weekly Gain

ACADIA Pharmaceuticals (NASDAQ: ACAD  )

$12.54

63%

VirnetX Holdings (NYSEMKT: VHC  )

$20.22

23%

The Active Network (NYSE: ACTV  )

$4.93

16%

Exelixis (NASDAQ: EXEL  )

$5.02

14%

MagicJack VocalTec (NASDAQ: CALL  )

$17.24

10%

Source: Barron's.

Let's start with ACADIA. The biotech soared after receiving an expedited review path from the FDA for its promising treatment of Parkinson's-related hallucinations. Investors will still have to be patient, as the application for reviewing pimavanserin won't happen until late next year. However, that's still far sooner than many were expecting.

VirnetX Holdings moved higher after the European Patent Office added a patent for third-party VPN certification to the company's already impressive portfolio of intellectual capital. After a disappointing ruling earlier this month in VirnetX's patent-infringement battle, it's good to see news that breaks the company's way.

The Active Network -- the leader in online registrations for triathlons, marathons, and other endurance events -- laced up its shoes and began running uphill after expanding its relationship with Ironman. A new three-year deal will build on Active's services through nearly 190 endurance events across five different brands.

Exelixis presented encouraging preclinical data on its lead compound's effectiveness in combating cancer tumors that have metastasized to the bone. In a presentation at the annual American Association for Cancer Research meeting, a poster revealed that treatment of tumor-bearing animals on cabozantinib resulted in inhibition of tumor growth.

Shares of magicJack VocalTec soared 12% a week earlier after posting its first annual operating profit since 1996. The rally continued this week, and it may be telephony pioneer itself ready to step up as a buyer. Bloomberg reported this week that magicJack's CEO has suggested expanding the company's stock-buyback program earlier this month.

Keep the good vibes coming
The best investing approach is to choose great companies and stick with them for the long term. The Motley Fool's free report "
3 Stocks That Will Help You Retire Rich" names stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On April 26, 2013, at 9:10 PM, billanthonyBA wrote:

    Marathon Patent Group has something to offer that VirnetX does not.

    Marathon Patent (MARA) has two segments: its own IP Licensing and Enforcement and IP Services divisions. What is interesting is that the company recently filed an IP suit against Sony, Dell, Blue Shield and Blue Cross and other Blue Chip companies (see April 25, 2013 press release). At the same time it assists other companies in filling patent holes in their patent portfolios, license patents, and defend against patent trolls. Should VirnetX implement this business model?

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2362272, ~/Articles/ArticleHandler.aspx, 10/1/2014 11:01:11 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement